Griffin Asset Management Inc. Sells 791 Shares of Danaher Corporation $DHR

Griffin Asset Management Inc. reduced its stake in Danaher Corporation (NYSE:DHR) by 1.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 49,889 shares of the conglomerate’s stock after selling 791 shares during the period. Danaher makes up approximately 1.2% of Griffin Asset Management Inc.’s investment portfolio, making the stock its 29th biggest position. Griffin Asset Management Inc.’s holdings in Danaher were worth $9,855,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. MGO One Seven LLC boosted its stake in shares of Danaher by 44.3% in the second quarter. MGO One Seven LLC now owns 36,228 shares of the conglomerate’s stock valued at $7,156,000 after buying an additional 11,130 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in shares of Danaher by 579.2% in the second quarter. Allspring Global Investments Holdings LLC now owns 375,863 shares of the conglomerate’s stock valued at $75,586,000 after buying an additional 320,521 shares during the period. Index Fund Advisors Inc. bought a new stake in shares of Danaher in the second quarter valued at approximately $453,000. Acorn Creek Capital LLC boosted its stake in shares of Danaher by 67.6% in the second quarter. Acorn Creek Capital LLC now owns 3,273 shares of the conglomerate’s stock valued at $646,000 after buying an additional 1,320 shares during the period. Finally, LRI Investments LLC boosted its stake in shares of Danaher by 2.3% in the second quarter. LRI Investments LLC now owns 4,354 shares of the conglomerate’s stock valued at $860,000 after buying an additional 96 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research analysts have commented on DHR shares. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Friday, June 27th. Barclays restated an “overweight” rating and set a $225.00 price objective (up from $215.00) on shares of Danaher in a research report on Tuesday, June 24th. Wells Fargo & Company lowered their price objective on shares of Danaher from $210.00 to $205.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 23rd. Guggenheim restated a “buy” rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, July 23rd. Finally, Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research report on Friday, July 11th. Seventeen analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $244.60.

Insiders Place Their Bets

In related news, Director Teri List sold 2,778 shares of the stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director directly owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 11.10% of the stock is owned by insiders.

Danaher Stock Down 1.0%

Shares of NYSE:DHR opened at $202.53 on Monday. The company has a fifty day moving average of $200.66 and a 200-day moving average of $197.07. The company has a market capitalization of $145.02 billion, a PE ratio of 43.09, a price-to-earnings-growth ratio of 2.88 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.41.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.64 by $0.16. The company had revenue of $5.94 billion during the quarter, compared to the consensus estimate of $5.83 billion. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The company’s revenue for the quarter was up 3.4% compared to the same quarter last year. During the same period in the prior year, the business earned $1.72 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is presently 27.23%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.